ProfileGDS5678 / 1457612_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 51% 48% 48% 44% 47% 48% 45% 48% 47% 51% 48% 43% 47% 49% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2708451
GSM967853U87-EV human glioblastoma xenograft - Control 23.1400948
GSM967854U87-EV human glioblastoma xenograft - Control 33.1371148
GSM967855U87-EV human glioblastoma xenograft - Control 42.9605744
GSM967856U87-EV human glioblastoma xenograft - Control 53.0660147
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2415548
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1251545
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1180248
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.086547
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2181751
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1159548
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.9609243
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1277347
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1603149